KIMS IPO GMP, Grey Market Premium & Kostak Rates Today

Table of Contents

Check out Krishna Institute of Medical Sciences aka KIMS IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. As there are 4 IPOs in the same date range investors will try to subscribe the best IPOs. The grey market premium is fluctuating. The lower subscription numbers and lower interest of investors affected the KIMS IPO GMP.

KIMS IPO to hit the market on 16 June 2021 and closes on 18 June 2021. The company to raise ₹2144 crore via initial public offer. They are one of the largest health care group and doing good in this tough situation. They have around 3000 bed capacity including over 2,500 operational beds and operating through 9 mumulti-speciality hospitals under their brand name KIMS Hospital. The price band of the IPO is ₹815 to ₹825. The KIMS IPO to list on NSE and BSE.

Krishna Institute of Medical Sciences Ltd

    What is KIMS IPO GMP Today?

    • The KIMS IPO GMP aka grey market premium is ₹110.

    What is KIMS IPO Kostak Rates Today?

    • The KIMS IPO kostak rate is ₹0.

    What is KIMS IPO Subject to Sauda Price Today?

    • The KIMS IPO subject to sauda rates is ₹0.

    KIMS IPO Expected Returns?

    • The KIMS expected return is 10%.

    KIMS IPO GMP Rates day by day with Kotak rates.

    KostakSubject to
    28 June₹100₹0₹0
    27 June₹100₹0₹0
    26 June₹110₹0₹0
    25 June₹70₹0₹0
    24 June₹50₹0₹0
    23 June₹60₹0₹0
    22 June₹40₹0₹0
    21 June₹30₹0₹0
    20 June₹30₹0₹0
    19 June₹30₹0₹0
    18 June₹50₹200₹0
    17 June₹70₹250₹0
    16 June₹35₹0₹0
    15 June₹40₹0₹0
    14 June₹120₹0₹0
    13 June₹0₹0₹0
    12 June₹0₹0₹0
    11 June₹0₹0₹0
    10 June₹0₹0₹0
    09 June₹0₹0₹0
    08 June₹0₹0₹0
    07 June₹0₹0₹0
    06 June₹0₹0₹0

    About KIMS

    We are one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered, according to the CRISIL Report. We provide multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary and quaternary healthcare in Tier 1 cities. We operate 9 multi-specialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of December 31, 2020, which is 2.2 times more beds than the second largest provider in AP and Telangana, according to the CRISIL report. We offer a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

    We have grown from a single hospital to a chain of multi-speciality hospitals through organic growth and strategic acquisitions under the leadership of Dr. Bhaskara Rao Bollineni, our founder and Managing Director, and Dr. Abhinay Bollineni, our Executive Director and CEO. Our first hospital in our network was established in Nellore in 2000 and has a capacity of approximately 200 beds. Our flagship hospital at Secunderabad is one of the largest private hospitals in India at a single location (excluding medical colleges), according to the CRISIL Report, with a capacity of 1,000 beds. We have significantly expanded our hospital network in recent years through our acquisitions of hospitals in Ongole in Fiscal Year 2017, Vizag and Anantapur in Fiscal Year 2019 and Kurnool in Fiscal Year 2020. Approximately one-third of our 3,064 beds were launched in the last four years. We have added over 880 beds, in aggregate, in our hospitals in Visakhapatnam (Vizag), Anantapur and Kurnool in Fiscal Years 2019 and 2020, and improved the overall bed occupancy rate in these hospitals from 71.83% to 80.49% in the same period. We strive to provide quality service to more patients, and we believe we have scope for additional patients and improved occupancy rates. We strategically focus on the southern India healthcare market where we have a strong understanding of regional nuances, customer culture and the mind-set of medical professionals and where there is significant and growing need for quality and affordable healthcare services. Each of our hospitals also has integrated diagnostic services and pharmacies that cater to our patients.

    Dr. Bhaskara Rao Bollineni is a renowned cardiothoracic surgeon in India. He has over 27 years of experience in cardiothoracic surgery and has worked in several other leading medical institutions in the country. He started KIMS Nellore in the year 2000 with the vision to create a hospital system for his home state of AP that is capable of attracting top medical talent and providing high-quality care at affordable prices. Under his leadership, and that of Dr. Abhinay Bollineni, who joined KIMS in 2014, we have expanded into nine cities across AP and Telangana through a combination of greenfield, brownfield and acquisition-led expansion. Dr. Abhinay assumed our CEO position in 2019 and played a leadership role in expanding the KIMS’ network over the last 5 years, including in the launch of KIMS Kondapur and the acquisitions of our hospitals in Ongole, Vizag, Anantapur and Kurnool. Today, our current network consists of hospitals strategically located to serve the healthcare needs of AP and Telangana across urban Tier 1 cities such as Secunderabad and Hyderabad and more rural Tier 2-3 areas such as Vizag, Nellore, Rajahmundry, Srikakulam, Ongole, Anantapur and Kurnool. We believe our hospitals are also situated well to capture patient in-flow across AP and Telangana and from the neighboring states of Karnataka, Odisha, Tamil Nadu and parts of central India. We also believe that affordability and quality of healthcare services provided by us and our track record of building long-term relationships with medical professionals including our doctors, has enabled our growth and helped us build our ‘KIMS Hospitals’ brand.

    KIMS IPO Date & Price Band

     IPO Open: 16 June 2021
     IPO Close: 18 June 2021
     IPO Size: Approx ₹2144 Crores
     Fresh Issue: Approx ₹200 Crores
     Offer for Sale: Approx 23,560,538 equity shares – ₹1944 Crores
     Face Value: ₹10 Per Equity Share
     Price Band: ₹815 to ₹825 Per Share
     Listing on: BSE & NSE
     Retail Portion: 10%
     Equity: 23,560,538 Shares
     Employee Discount: ₹40 Per Equity Share

    KIMS IPO Market Lot

     Minimum Lot Size: Minimum 18 Shares
     Minimum Amount: ₹14,850
     Maximum Lot Size: Maximum 234 Shares
     Maximum Amount: ₹1,93,050

    KIMS IPO Allotment & Listing

     Basis of Allotment: 23 June 2021
     Refunds: 24 June 2021
     Credit to Demat Account: 25 June 2021
     Listing Date: 28 June 2021

    KIMS IPO GMP aka Grey Market Premium FAQs:

    What is KIMS IPO GMP Today?

    KIMS IPO GMP is ₹110 as on today.

    What How much is KIMS IPO Kostak Rate Today?

    KIMS IPO Kostak Rate is ₹0 as on today.

    What is KIMS IPO Subject to Sauda Today?

    KIMS IPO Subject to Sauda is ₹0 as on today.

    What is KIMS IPO Expected Returns?

    KIMS IPO Expected Returns is 10% .


    •  IPO Grey Market Premium (KIMS IPO GMP) mention is valid for the specific date as mentioned in the header.
    •  We are not buying and selling IPO forms on IPO Grey Market.
    •  Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
    • Do not subscribe for IPO by just seeing premium Price as it may change anytime before listing. Subscribe only considering Fundamental of the companies.
    Share the Post:

    Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on TwitterFacebook, and Instagram. For our latest videos, subscribe to our YouTube channel.